News Conference News EuroPCR 2025 OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI L.A. McKeown May 28, 2025
News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Conference News ESC 2024 More Support for Ticagrelor Monotherapy After PCI, Especially in ACS Yael L. Maxwell September 10, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News ACC 2023 AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup L.A. McKeown March 09, 2023
News Daily News Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD Yael L. Maxwell November 21, 2022
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Daily News ‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent Caitlin E. Cox March 07, 2017
News Daily News Primary PCI Reduces Symptoms vs. Fibrinolysis 5 Years after STEMI L.A. McKeown January 01, 2014
News Daily News La PCI Primaria Reduce los Síntomas frente a la Fibrinolisis 5 Años después de un Cuadro de STEMI L.A. McKeown January 01, 2014